ABMC Stock Overview
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
American Bio Medica Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0003 |
| 52 Week High | US$0.017 |
| 52 Week Low | US$0.000001 |
| Beta | 1.97 |
| 1 Month Change | 0% |
| 3 Month Change | 29,900.00% |
| 1 Year Change | -97.03% |
| 3 Year Change | -99.64% |
| 5 Year Change | -99.57% |
| Change since IPO | -99.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| ABMC | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | 1.6% | 1.0% |
| 1Y | -97.0% | -1.4% | 21.9% |
Return vs Industry: ABMC underperformed the US Medical Equipment industry which returned -0.5% over the past year.
Return vs Market: ABMC underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| ABMC volatility | |
|---|---|
| ABMC Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: ABMC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine ABMC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 20 | n/a | www.abmc.com |
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat.
American Bio Medica Corporation Fundamentals Summary
| ABMC fundamental statistics | |
|---|---|
| Market cap | US$14.43k |
| Earnings (TTM) | US$850.00k |
| Revenue (TTM) | US$726.00k |
0.0x
P/E Ratio0.0x
P/S RatioIs ABMC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ABMC income statement (TTM) | |
|---|---|
| Revenue | US$726.00k |
| Cost of Revenue | US$873.00k |
| Gross Profit | -US$147.00k |
| Other Expenses | -US$997.00k |
| Earnings | US$850.00k |
Last Reported Earnings
Mar 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.018 |
| Gross Margin | -20.25% |
| Net Profit Margin | 117.08% |
| Debt/Equity Ratio | -38.2% |
How did ABMC perform over the long term?
See historical performance and comparison